Literature DB >> 5307809

The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.

A D Steinberg, S Baron, N Talal.   

Abstract

Antibodies to DNA and RNA were induced in young NZB/NZW F(1) (B/W) female mice following multiple injections of the interferon-inducer polyinosinic.polycytidylic acid (poly I.poly C). Despite serum concentrations of interferon adequate to inhibit the C-type murine leukemia viruses, there was an acceleration of the autoimmune disease in these animals. Anti-RNA, but not anti-DNA antibodies, were induced in B/W male mice, as well as in NZB and NZW mice. Anti-RNA antibodies were also found in 50 per cent of female B/W mice who had never received poly I.poly C and in 8 of 24 sera from patients with systemic lupus erythematosus. These results suggest that double-stranded RNA functions as a potent antigen in New Zealand mice. Naturally occurring nucleic acids (e.g., viruses) probably act as stimuli to a genetically hyperreactive immune system. According to this hypothesis, the unusual feature in this disease is not a unique virus, but rather the unique genetic susceptibility of the B/W (particularly female) host to immunization with nucleic acids. A similar pathogenetic mechanism may be operative in some humans with systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5307809      PMCID: PMC223434          DOI: 10.1073/pnas.63.4.1102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Some factors affecting the interferon-induced antiviral state.

Authors:  S Baron; C E Buckler; H B Levy; R M Friedman
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

2.  Effect of statolon on Friend virus leukemia in mice.

Authors:  E F Wheelock
Journal:  Proc Soc Exp Biol Med       Date:  1967-03

3.  [Antigenicity of polynucleotide complexes].

Authors:  E Nahon; A M Michelson; F Lacour
Journal:  Biochim Biophys Acta       Date:  1967-11-21

4.  Family studies in systemic lupus erythematosus.

Authors:  E T Leonhardt
Journal:  Clin Exp Immunol       Date:  1967-12       Impact factor: 4.330

5.  Rapid loss of tolerance induced in weanling NZB and B-W F1 mice.

Authors:  P J Staples; N Talal
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

6.  Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.

Authors:  A K Field; A A Tytell; G P Lampson; M R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

7.  Interferon and murine leukemia. I. Inhibitory effect of interferon preparations on development of friend leukemia in mice.

Authors:  I Gresser; J Coppey; E Falcoff; D Fontaine
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

8.  Pathogenesis of the glomerulonephritis of NZB/W mice.

Authors:  P H Lambert; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

9.  Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice.

Authors:  P J Staples; N Talal
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  51 in total

1.  Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset.

Authors:  Uma Sriram; Linda Varghese; Heather L Bennett; Neelakshi R Jog; Debra K Shivers; Yue Ning; Edward M Behrens; Roberto Caricchio; Stefania Gallucci
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  Effect of glucan on murine lupus evolution and on host resistance to Klebsiella pneumoniae.

Authors:  H A Harima; N F Mendes; E M Mamizuka; M Mariano
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

3.  Interferon treatment of NZB mice: accelerated progression of autoimmune disease.

Authors:  H Heremans; A Billiau; A Colombatti; J Hilgers; P de Somer
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.

Authors:  S-R Nandula; Y M Scindia; P Dey; H Bagavant; U S Deshmukh
Journal:  Oral Dis       Date:  2011-08-04       Impact factor: 3.511

Review 5.  Type I interferon in the pathogenesis of lupus.

Authors:  Mary K Crow
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

6.  Genesis of antinuclear antibody in NZB-W mice: role of genetic factors and of viral infections.

Authors:  P H Lambert; F J Dixon
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

7.  A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid.

Authors:  W-M Qu; T Miyazaki; M Terada; K Okada; S Mori; H Kanno; M Nose
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

8.  Immunopathology of nephritis in Africa.

Authors: 
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

9.  Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon.

Authors:  D Sergiescu; I Cerutti; A Kahan; D Piatier; E Efthymiou
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

10.  Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies.

Authors:  T H Bacon; A de Vere-Tyndall; D A Tyrrell; A M Denman; B M Ansell
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.